CRISPR Therapeutics AG Insider Trading for October 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CRISPR Therapeutics AG.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in CRISPR Therapeutics AG for October 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 26 2016 | CRSP | CRISPR Therapeutic ... | COLES N ANTHONY | Director | Grant | A | 14.00 | 35,000 | 490,000 | 70,000 | 35 K to 70 K (+100.00 %) |
| Oct 26 2016 | CRSP | CRISPR Therapeutic ... | COLES N ANTHONY | Director | Grant | A | 14.00 | 35,000 | 490,000 | 70,000 | 35 K to 70 K (+100.00 %) |
| Oct 26 2016 | CRSP | CRISPR Therapeutic ... | Versant Venture Capital IV, L. ... | 10% Owner | Grant | A | 14.00 | 4,583 | 64,162 | 185,987 | 181.4 K to 186 K (+2.53 %) |
| Oct 26 2016 | CRSP | CRISPR Therapeutic ... | Versant Venture Capital IV, L. ... | 10% Owner | Grant | A | 14.00 | 60,219 | 843,066 | 2,443,803 | 2.4 M to 2.4 M (+2.53 %) |
| Oct 26 2016 | CRSP | CRISPR Therapeutic ... | Versant Venture Capital IV, L. ... | 10% Owner | Grant | A | 14.00 | 602 | 8,428 | 24,334 | 23.7 K to 24.3 K (+2.54 %) |
| Oct 26 2016 | CRSP | CRISPR Therapeutic ... | Versant Venture Capital IV, L. ... | 10% Owner | Grant | A | 14.00 | 95,596 | 1,338,344 | 4,104,045 | 4 M to 4.1 M (+2.38 %) |
| Oct 26 2016 | CRSP | CRISPR Therapeutic ... | George Simeon | Director | Option Exercise | C | 0.00 | 211,567 | 0 | 0 | |
| Oct 26 2016 | CRSP | CRISPR Therapeutic ... | George Simeon | Director | Option Exercise | C | 0.00 | 2,942,560 | 0 | 0 | |
| Oct 26 2016 | CRSP | CRISPR Therapeutic ... | George Simeon | Director | Buy | P | 14.00 | 66,500 | 931,000 | 3,220,627 | 3.2 M to 3.2 M (+2.11 %) |
| Oct 26 2016 | CRSP | CRISPR Therapeutic ... | George Simeon | Director | Buy | C | 0.00 | 211,567 | 0 | 3,154,127 | 2.9 M to 3.2 M (+7.19 %) |
| Oct 26 2016 | CRSP | CRISPR Therapeutic ... | George Simeon | Director | Buy | C | 0.00 | 2,942,560 | 0 | 2,942,560 | 0 to 2.9 M |
| Oct 26 2016 | CRSP | CRISPR Therapeutic ... | GLAXOSMITHKLINE PLC | 10% Owner | Option Exercise | C | 0.00 | 211,567 | 0 | 0 | |
| Oct 26 2016 | CRSP | CRISPR Therapeutic ... | GLAXOSMITHKLINE PLC | 10% Owner | Option Exercise | C | 0.00 | 2,942,560 | 0 | 0 | |
| Oct 26 2016 | CRSP | CRISPR Therapeutic ... | GLAXOSMITHKLINE PLC | 10% Owner | Buy | P | 14.00 | 66,500 | 931,000 | 3,220,627 | 3.2 M to 3.2 M (+2.11 %) |
| Oct 26 2016 | CRSP | CRISPR Therapeutic ... | GLAXOSMITHKLINE PLC | 10% Owner | Buy | C | 0.00 | 211,567 | 0 | 3,154,127 | 2.9 M to 3.2 M (+7.19 %) |
| Oct 26 2016 | CRSP | CRISPR Therapeutic ... | GLAXOSMITHKLINE PLC | 10% Owner | Buy | C | 0.00 | 2,942,560 | 0 | 2,942,560 | 0 to 2.9 M |
| Oct 26 2016 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Option Exercise | C | 0.00 | 4,034,830 | 0 | 0 | |
| Oct 26 2016 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Buy | P | 14.00 | 800,150 | 11,202,100 | 4,834,980 | 4 M to 4.8 M (+19.83 %) |
| Oct 26 2016 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Buy | C | 0.00 | 4,034,830 | 0 | 4,034,830 | 0 to 4 M |
| Oct 24 2016 | CRSP | CRISPR Therapeutic ... | Hadley Harbor Master Investors ... | 10% Owner | Option Exercise | C | 0.00 | 744,380 | 0 | 0 | |
| Oct 24 2016 | CRSP | CRISPR Therapeutic ... | Hadley Harbor Master Investors ... | 10% Owner | Buy | C | 0.00 | 744,380 | 0 | 744,380 | 0 to 744.4 K |
| Oct 20 2016 | CRSP | CRISPR Therapeutic ... | GLAXOSMITHKLINE PLC | 10% Owner | Option Exercise | A | 14.00 | 30,000 | 420,000 | 30,000 | |
| Oct 20 2016 | CRSP | CRISPR Therapeutic ... | Behbahani Ali | Director | Option Exercise | A | 14.00 | 30,000 | 420,000 | 30,000 | |
| Oct 20 2016 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Option Exercise | A | 14.00 | 200,000 | 2,800,000 | 200,000 | |
| Oct 20 2016 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Option Exercise | A | 14.00 | 30,000 | 420,000 | 30,000 | |
| Oct 20 2016 | CRSP | CRISPR Therapeutic ... | EMSTER KURT VON | Director | Option Exercise | A | 14.00 | 30,000 | 420,000 | 30,000 | |
| Oct 20 2016 | CRSP | CRISPR Therapeutic ... | COLES N ANTHONY | Director | Option Exercise | A | 14.00 | 15,000 | 210,000 | 15,000 | |
| Oct 20 2016 | CRSP | CRISPR Therapeutic ... | CAGNONI PABLO J | Director | Option Exercise | A | 14.00 | 15,000 | 210,000 | 15,000 | |
| Oct 20 2016 | CRSP | CRISPR Therapeutic ... | George Simeon | Director | Option Exercise | A | 14.00 | 30,000 | 420,000 | 30,000 | |
| Oct 20 2016 | CRSP | CRISPR Therapeutic ... | Woiwode Thomas | Director | Option Exercise | A | 14.00 | 30,000 | 420,000 | 30,000 |